Interleukin-12 Antagonist drugs compared
Compare all 3 Interleukin-12 Antagonist drugs side by side, used for conditions such as colitis, ulcerative, crohn disease, psoriasis. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores.
Full ranking · 3 drugs
Frequently asked questions
What is the Interleukin-12 Antagonist drug class?
Interleukin-12 Antagonist is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 3 Interleukin-12 Antagonist products, each independently rated.
Are all Interleukin-12 Antagonist drugs the same?
No. Interleukin-12 Antagonist drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.
What conditions do Interleukin-12 Antagonist drugs treat?
Per NIH RxClass drug-classification data, Interleukin-12 Antagonist drugs are used for conditions including colitis, ulcerative, crohn disease, psoriasis, arthritis, psoriatic.
Sources: the Interleukin-12 Antagonist class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class). Ratings are pharmaranks’ independent FDA recall-safety analysis.